These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6115899)

  • 1. Uniformity of content requirements for tablets and capsules.
    Kendall CE; Low GK; Hailey DM
    J Pharm Pharmacol; 1981 Apr; 33(4):197-202. PubMed ID: 6115899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter: USP content uniformity test.
    Madan PL
    J Pharm Sci; 1976 Jan; 65(1):VIII. PubMed ID: 1255410
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Dissolution test blossoms.
    Feldmann EG
    J Pharm Sci; 1976 Apr; 65(4):I. PubMed ID: 1271242
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing for uniformity: sampling plans in pharmacopeias for weight, volume, and content uniformity.
    Pietra V; Setnikar I
    J Pharm Sci; 1970 Apr; 59(4):530-5. PubMed ID: 5440682
    [No Abstract]   [Full Text] [Related]  

  • 5. Particle size limits to meet USP content uniformity criteria for tablets and capsules.
    Rohrs BR; Amidon GE; Meury RH; Secreast PJ; King HM; Skoug CJ
    J Pharm Sci; 2006 May; 95(5):1049-59. PubMed ID: 16552749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution test acceptance sampling plans.
    Tsong Y; Hammerstrom T; Lin K; Ong TE
    J Biopharm Stat; 1995 Jul; 5(2):171-83. PubMed ID: 7581426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The study of the applicability of content uniformity and weight variation test--the state of commercial tablets and capsules in Japan.
    Katori N; Aoyagi N; Kojima S
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1412-9. PubMed ID: 11724231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some properties of the USP content-uniformity test as related to control charts and validation of solid dosage forms.
    Bolton S
    J Pharm Sci; 1985 May; 74(5):572-4. PubMed ID: 4020637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets].
    Tao QF; Zhong DF; Luo X; Wang X
    Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209
    [No Abstract]   [Full Text] [Related]  

  • 10. Content uniformity and assay requirements in current regulations.
    Bánfai B; Ganzler K; Kemény S
    J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical analysis of the USP 18 content uniformity sampling plan for tablets.
    Langenbucher F
    Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of blend uniformity and content uniformity based on 2003 stratified sampling guidance and 1999 blend uniformity analysis guidance: product A.
    Howard-Sparks M; Gawlikowski A;
    PDA J Pharm Sci Technol; 2004; 58(4):222-30. PubMed ID: 15368992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of medication dose uniformity in commonly split tablets.
    Teng J; Song CK; Williams RL; Polli JE
    J Am Pharm Assoc (Wash); 2002; 42(2):195-9. PubMed ID: 11926662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective visual evaluation of the relative content of major and minor defects in tablets and capsules.
    Stone JC
    J Pharm Sci; 1970 Sep; 59(9):1364. PubMed ID: 5469814
    [No Abstract]   [Full Text] [Related]  

  • 16. The USP content uniformity test. Analysis and proposals.
    Setnikar I
    Pharm Acta Helv; 1974; 49(9-10):302-8. PubMed ID: 4462139
    [No Abstract]   [Full Text] [Related]  

  • 17. Physicochemical quality profiles of commercial oral tablets and capsules containing lutein - impact of insufficient specific sanitary regulations.
    Anselmo CS; Mendes TC; Cabral LM; Sousa VP
    An Acad Bras Cienc; 2018; 90(3):3063-3073. PubMed ID: 30043910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three pharmaceutical products obtained from Mexico and the United States: a case study.
    Karlage KL; Myrdal PB
    Drug Dev Ind Pharm; 2005 Dec; 31(10):993-1000. PubMed ID: 16316855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content uniformity of potent drugs in tablets.
    Orr NA; Sallam EA
    J Pharm Pharmacol; 1978 Dec; 30(12):741-7. PubMed ID: 32236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass variation tests for coating tablets and hard capsules: rational application of mass variation tests.
    Katori N; Aoyagi N; Kojima S
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1176-80. PubMed ID: 12237532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.